|
|
TTD Drug ID:
DNC008922
Drug
Information |
Name | (R)-(-)-alpha-methylhistamine | (R)-2-(1H-Imidazol-4-yl)-1-methyl-ethylamine | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C6H11N3/c1-5(7)2-6-3-8-4-9-6/h3-5H,2,7H2,1H3,(H,8,9)/t5-/m1/s1 | InChIKey | XNQIOISZPFVUFG-RXMQYKEDSA-N | Canonical SMILES | CC(CC1=CN=CN1)N | Isomeric SMILES | C[C@H](CC1=CN=CN1)N | Target | Histamine H3 receptor |  | Inhibitor | [1] | Histamine H4 receptor |  | Inhibitor | [2] | Ref 1 | J Med Chem. 1995 May 12;38(10):1593-9.A novel pyrrolidine analog of histamine as a potent, highly selective histamine H3 receptor agonist. To Reference | Ref 2 | J Med Chem. 2008 Jun 12;51(11):3145-53. Epub 2008 May 7.Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|